Global Endocrine Testing Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Endocrine Testing Industry By The Forecast Year 2029?

The endocrine testing market size has experienced substantial growth in recent years. It is projected to expand from $2.55 billion in 2024 to $2.79 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.6%. The historical growth of this market can be attributed to the discovery of hormones and endocrine pathways, the standardization of diagnostic tests, public health initiatives, and patient advocacy and empowerment.

The endocrine testing market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $3.89 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.7%. This forecasted growth is largely driven by factors such as the rising incidence of endocrine disorders, increased defense spending, an expanding elderly demographic, enhanced awareness, and earlier diagnostic efforts. Key developments expected during this period involve progress in biomarker identification, the incorporation of omics technologies, the application of artificial intelligence and machine learning, a focus on quality assurance and standardization, and collaborative research initiatives alongside translational medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

What Are The Drivers Pushing New Developments In The Endocrine Testing Market?

The growing number of diabetes cases is projected to fuel the expansion of the endocrine testing market in the future. Diabetes is characterized by conditions leading to elevated blood sugar (glucose) levels. Its increasing occurrence is attributed to factors such as unhealthy eating habits, inactive lifestyles, genetic predispositions, and an aging global demographic. Endocrine testing, encompassing procedures like hemoglobin A1c, fasting plasma glucose, and C-peptide tests, plays a crucial role in diabetes for diagnosis, monitoring glucose concentrations, and evaluating insulin production and sensitivity. For instance, in June 2024, the National Health Service (NHS), a UK-based government department, observed an increase in diabetes cases among individuals under 40, climbing from 173,166 in 2022 to 216,440 in 2023. This notable surge highlights a significant and concerning trend within this age group, indicating a swift rise in diabetes prevalence among younger demographics. Consequently, the escalating prevalence of diabetes is a primary driver for the endocrine testing market.

Which Key Segments Fueling The Endocrine Testing Market?

The endocrine testingmarket covered in this report is segmented –

1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types

2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies

3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users

Subsegments:

1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test

2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test

3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test

4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test

5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test

6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test

7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test

8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test

9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test

10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test

What Key Innovation Trends Are Fueling Advancements In The Endocrine Testing Market?

Leading companies in the endocrine testing market are actively developing point-of-care testing solutions to improve both the accessibility and efficiency of diagnosing endocrine disorders. This type of testing delivers quick results, which can significantly assist in the rapid diagnosis and management of heart failure among patients who present with symptoms such as shortness of breath and fatigue. For example, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced a point-of-care NT-proBNP test in India. This test was specifically created for screening diabetes patients who are at an elevated risk of cardiovascular diseases, including heart failure (HF). The test enables early detection and intervention, empowering clinicians to pinpoint high-risk T2D patients and initiate prompt discussions about their treatment, ultimately contributing to improved outcomes and patient well-being.

Which Major Industry Participants Are Leading The Endocrine Testing Market Growth?

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

Which Region Is Projected To Lead The Endocrine Testing Market During The Forecast Period?

North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Endocrine Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15562&type=smp

Browse Through More Reports Similar to the Global Endocrine Testing Market 2025, By The Business Research Company

Endoscopy Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endoscopy-devices-and-equipment-global-market-report

Endoscope Reprocessing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endoscope-reprocessing-global-market-report

Endodontics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endodontics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795